Lexington Medical, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lexington Medical, Inc. - overview
Established
2013
Location
Bedford, MA, US
Primary Industry
Medical Devices & Equipment
About
Lexington Medical, Inc. is a Boston-based medical device company specializing in innovative minimally invasive surgical stapling solutions designed to enhance clinical performance in various surgical applications. Founded in 2013 in Bedford, US, Lexington Medical, Inc. manufactures surgical devices, notably the AEON™ Powered Stapling System, which focuses on improving surgical precision.
The firm has completed one deal as of April 17, 2025. The company's founder has a history in the medical device sector, though specific prior ventures are not documented. Lexington Medical specializes in manufacturing minimally invasive surgical stapling solutions, with their flagship product being the AEON™ Powered Stapling System. This innovative system incorporates advanced engineering and proprietary technologies to improve clinical performance in surgical applications, particularly in thoracic, bariatric, and hepatobiliary surgery.
The AEON™ endostapler is engineered to meet critical surgical needs by reducing staple line bleeding and enhancing patient outcomes. Its primary customers include healthcare professionals, particularly surgeons and medical institutions, ensuring reliable staple line integrity during procedures. The products are marketed across North America, Europe, and parts of Asia, targeting healthcare providers committed to adopting innovative surgical technologies. Lexington Medical generates revenue from direct sales of their surgical stapling devices, especially the AEON™ Powered Stapling System, to hospitals and surgical centers.
Sales occur through B2B partnerships where healthcare institutions procure devices based on clinical needs and specific surgical procedures, either through bulk purchasing agreements or one-time transactions. The pricing for the AEON™ system reflects its premium quality and features aimed at enhancing surgical outcomes, with revenue derived from ongoing client relationships emphasizing product performance and customer service. Lexington Medical plans to enhance its product portfolio by launching new surgical stapling solutions in 2025, building on the success of the AEON™ system. The company is targeting expansion into European and Asian markets by the end of 2026 to increase its global presence.
The recent investment from Ampersand Capital Partners in April 2025 will support these growth initiatives and assist in broadening market reach.
Current Investors
Ampersand
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.lexington-med.com/
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Lexington Medical, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Lexington Medical, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.